# DOMME Dose Optimization Multicentric Mexican Evaluation

> **NCT00488527** · PHASE4 · COMPLETED · sponsor: **Sanofi** · enrollment: 371 (actual)

## Conditions studied

- Diabetes Mellitus, Type 2

## Interventions

- **DRUG:** Insulin glargine

## Key facts

- **NCT ID:** NCT00488527
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-04
- **Primary completion:** 2008-12
- **Final completion:** 2008-12
- **Target enrollment:** 371 (ACTUAL)
- **Last updated:** 2010-09-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00488527

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00488527, "DOMME Dose Optimization Multicentric Mexican Evaluation". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00488527. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*